Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease

被引:1
|
作者
Lozano-Sanroma, Javier [1 ]
Barros, Alberto [1 ]
Alcalde, Ignacio [1 ,2 ]
Alvarado-Villacorta, Rosa [1 ]
Sanchez-Avila, Ronald M. [3 ]
Queiruga-Pineiro, Juan [1 ]
Cueto, Luis Fernandez-Vega [1 ,2 ]
Anitua, Eduardo [3 ]
Merayo-Lloves, Jesus [1 ,2 ]
机构
[1] Inst Univ Fernandez Vega, Fdn Invest Oftalmol, Oviedo 33012, Spain
[2] Univ Oviedo, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo 33011, Spain
[3] Biotechnol Inst BTI, Regenerat Med Lab, Vitoria 01007, Spain
关键词
congenital aniridia; plasma rich in growth factors; PRGF; ocular redness; DED; OCULAR SURFACE; AUTOLOGOUS SERUM; DROPS; KERATOPATHY; MANAGEMENT; SYMPTOMS; EYEDROPS; REDNESS; INDEX; SIGNS;
D O I
10.3390/diseases12040076
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Congenital aniridia is a rare bilateral ocular malformation characterized by the partial or complete absence of the iris and is frequently associated with various anomalies, including keratopathy, cataract, glaucoma, and foveal and optic nerve hypoplasia. Additionally, nearly 50% of individuals with congenital aniridia experience symptoms of ocular dryness. Traditional treatment encompasses artificial tears and autologous serum. This study aimed to assess the effectiveness and safety of using platelet rich in growth factors (PRGF) plasma in patients with congenital aniridia and ocular dryness symptoms. Methods: The included patients underwent two cycles of a 3-month PRGF treatment. At 6 months, symptomatology was evaluated using the OSDI and SANDE questionnaires, and ocular surface parameters were analyzed. Results: The OSDI and SANDE values for frequency and severity demonstrated statistically significant improvements (p < 0.05). Ocular redness, corneal damage (corneal staining), and tear volume (Schirmer test) also exhibited statistically significant improvements (p < 0.05). No significant changes were observed in visual acuity or in the grade of meibomian gland loss. Conclusion: The use of PRGF in patients with congenital aniridia and ocular dryness symptoms led to significant improvements in symptomatology, ocular redness, and ocular damage. No adverse effects were observed during the use of PRGF.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study
    Protzko, Eugene E.
    Segal, Bruce A.
    Korenfeld, Michael S.
    Kroesser, Sonja
    Vittitow, Jason L.
    CORNEA, 2024, 43 (09) : 1100 - 1107
  • [42] Eyelid Exfoliation Treatment Efficacy and Safety in Dry Eye Disease, Blepharitis, and Contact Lens Discomfort Patients: A Systematic Review
    Ballesteros-Sanchez, Antonio
    Gargallo-Martinez, Beatriz
    Gutierrez-Ortega, Ramon
    Sanchez-Gonzalez, Jose-Maria
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2023, 12 (03): : 315 - 325
  • [43] Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease
    Tawfik, Andrew
    Pistilli, Maxwell
    Maguire, Maureen G.
    Chen, Yineng
    Yu, Yinxi
    Greiner, Jack, V
    Asbell, Penny A.
    Ying, Gui-Shuang
    OPHTHALMIC EPIDEMIOLOGY, 2024, 31 (03) : 274 - 282
  • [44] Efficacy of Perfluorohexyloctane for the Treatment of Patients with Dry Eye Disease: A Meta-Analysis
    Taloni, Andrea
    Coco, Giulia
    Pellegrini, Marco
    Scorcia, Vincenzo
    Giannaccare, Giuseppe
    OPHTHALMIC RESEARCH, 2025, 68 (01) : 41 - 51
  • [45] Perfluorohexyloctane in dry eye disease: A systematic review of its efficacy and safety as a novel therapeutic agent
    Ballesteros-Sanchez, Antonio
    De-Hita-Cantalejo, Concepcion
    Sanchez-Gonzalez, Maria Carmen
    Jansone-Langine, Zane
    de Sotomayor, Maria Alvarez
    Culig, Josip
    Sanchez-Gonzalez, Jose-Maria
    OCULAR SURFACE, 2023, 30 : 254 - 262
  • [46] The Efficacy and Safety of Qiming Granule for Dry Eye Disease: A Systematic Review and Meta-Analysis
    Yang, Maoyi
    Hu, Zhipeng
    Yue, Rensong
    Yang, Liangjun
    Zhang, Boxun
    Chen, Yuan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [47] Safety and efficacy of ibutilide in patients with atrial tachycardias and congenital heart disease
    Zimmerman, FJ
    Walsh, EP
    Saul, JP
    Epstein, MR
    DeLucca, J
    Triedman, JK
    CIRCULATION, 1997, 96 (08) : 1042 - 1042
  • [48] Patients' Perspectives on Their Dry Eye Disease
    Crnej, Alja
    Kheirkhah, Ahmad
    Ren, Ai
    Mullins, Andrew
    Lavric, Alenka
    Suri, Kunal
    Hamrah, Pedram
    Dana, Reza
    OCULAR SURFACE, 2016, 14 (04): : 440 - 446
  • [49] A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease
    Jerkins, Gary
    Greiner, Jack, V
    Tong, Louis
    Tan, Jacqueline
    Tauber, Joseph
    Mearza, Ali
    Srinivasan, Sruthi
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 1665 - 1673
  • [50] Dry eye syndrome in patients with allergic eye disease
    Acuna Ortega, Natalhie
    Gonzalez Diaz, Sandra
    Mohamed Hamsho, Jesus
    Mohamed Noriega, Karim
    Macias Weinmann, Alejandra
    Guzm Avilan, Rosa
    Santos Fernandez, Wendy
    Murillo Rodriguez, Jose
    Pacheco Gonzalez, Rodrigo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB217 - AB217